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The aim of this study was to identify quality indicators following 
robotic surgery in patients with endometrial cancer. Primary 
outcome measures were length of stay (LOS), estimated blood 
loss (EBL), and operative times (OR times). Secondary outcome 
measures were transfusion rates and perioperative complication 
rates.
Benchmarking Quality Metrics for Endometrial Cancer Patients:
Robotics vs. Laparoscopy
Objective:






     Mean + SD 62.4 + 11.9 63.7 + 12.2 0.321
BMI (kg/m2)
    Mean + SD 35.8 + 9.0 33.9 + 8.8 0.121
CANCER STAGE (n)
    I 139 93
  
    II 13 6
    III 16 4
    Not specified 39 31Methods:
Three hundred forty-one patients (207 robotic and 134 laparoscopic) 
were analyzed. There were no significant differences between the 
two groups in age, BMI, or cancer stage. (Table 1) For the robotic 
cohort, the median pelvic, periaortic and total nodal counts were 
12 (range: 1-34), 4 (range: 1-19), and 14 (range: 1-43). For the 
laparoscopic cohort, they were 12.5 (range: 2-22), 4 (range: 1-17), 
and 16 (range: 2-35), respectively. Five robotic cases (2.4%) and 10 
Results:
Patients with endometrial cancer who have robotic surgery 
experience shorter operative times, less blood loss, shorter length 
of stays, fewer transfusions and fewer complications compared 
to laparoscopic surgery.  These findings suggest surgical quality 
outcomes may be improved for patients who have robotic surgery for 
endometrial cancer.
Conclusion:
Martin A. Martino MD1; Jocelyn Shubella1; Shamol Williams2, Rachel Morcrette PA-C1, Jeremy Patriarco1, Hai-Yen Nguyen MD1, Amy Hordendorf1; M. Bijoy Thomas MD1; Richard Boulay MD1





PELVIC LYMPH NODE RETRIEVAL
   
     Median (Range) 12 (1-34) 12.5 (2-22)
PERIAORTIC LYMPH NODE RETRIEVAL
    Median (Range) 4 (1-19) 4 (1-17)
TOTAL LYMPH NODE RETRIEVAL
    Median (Range) 14 (1-43) 16 (2-35)
CONVERSION TO LAPAROTOMY
    N (%) 5 (2.4) 10 (7.5) .03
TRANSFUSIONS
    N (%) 1 (0.5) 12 (9.0) <.0001
OPERATIVE TIME (min)
    Median (Range) 161 (62-366) 180 (92-448) .01
TOTAL OR TIME (min)
    Median (Range) 229 (118-466) 253 (154-534) .03
ESTIMATED BLOOD LOSS (mL)
    Median (Range) 50 (10-1200) 150 (10-1600) <.001
LENGTH OF STAY (d)
    Median (Range) 1 (1-12) 1.5 (1-17) .002
PERIOPERATIVE COMPLICATIONS
    N (%) 19 (9.2%) 25 (18.7%) .01
•  From 6/2008 to 6/2011, all consecutive patients diagnosed 
with endometrial cancer who were scheduled for a robotic-
assisted hysterectomy by the gynecologic oncology service were 
prospectively captured. They were compared to a retrospective 
cohort of endometrial cancer patients who had a laparoscopic-
assisted hysterectomy from 9/2005 to 6/2011. 
•  Demographic data included age, BMI, and cancer stage. 
•  Outcome measures reviewed were lymph node retrieval, LOS, EBL, 
OR times, transfusion rates and complications. 
•  SPSS was used to perform Student’s t-tests and Pearson’s chi-
squared tests. 
•  This study was IRB-approved.
laparoscopic cases (7.5%) were converted to laparotomies (P=.03). 
One robotic case (.48%) and 12 laparoscopic cases (8.96%) received 
transfusions (P<.0001). Median operative time (skin incision to 
closure) was 161 min (range: 62-366) for robotics and 180 min (range: 
92-448) for laparoscopies (P=.01). Median OR room time was 229 min 
(range: 118-466) and 253 min (range: 154-534), respectively (P=.03). 
Median EBL was 50mL (range: 10-1200) for the robotic group and 
150mL (range: 10-1600) for the laparoscopic group (P<.001). Median 
LOS was 1 day (range: 1-12) for robotics and 1.5 days (range: 1-17) 
for laparoscopies (P=.002). Nineteen robotics patients experienced 
a perioperative complication (9.2%) compared to 25 laparoscopic 
patients (18.7%) (P=.01). (Table 2)
